Deep Brain Stimulation (DBS) Systems Market Worth USD 2,122.8 Million By 2027 | Emergen Research

VANCOUVER, B.C., Sept. 15, 2020 /PRNewswire/ -- The global Deep Brain Stimulation (DBS) Systems Market was valued at USD 1227.5 million in 2019 and is expected to reach USD 2,122.8 million by 2027, growing at a CAGR of 8.1% according to a new report by Emergen Research. In general, geriatric population suffers from unconscious movements of the body leading to Parkinson's disease, multiple sclerosis and dystonia. In the United States, more than 60,000 people are diagnosed with Parkinson's disease each year, with approximately 10 million people presently living with Parkinson's disease globally. High prevalence of such diseases among elderly coupled with rising geriatric population are fuelling up the demand for the deep brain stimulation systems worldwide. In addition, increasing incidences associated with depression, essential tremor and obsessive compulsive disorder (OCD) are further multiplying the demand of deep brain stimulation systems in the industry.

Minimally invasive surgical techniques play a considerable role in treating neurological symptoms like tremors, movement control and rigidity among other symptoms leading to Parkinson's disease and dystonia. The systems directed in deep brain stimulation safeguards minimal damage to the surrounding brain tissues. Technologically advanced implanted systems have an ability to get recharged wirelessly without further surgical activities. Furthermore, epilepsy is currently affecting more than 50 million people across the world accounting for a substantial proportion of the entire world's disease burden. Side effects linked with the surgery and associated drugs, high cost of treatment along with high cost of deep brain stimulation systems might restrict the industry growth in the forecast period.

Request free sample of this research report at:
https://www.emergenresearch.com/request-sample/45

Key Highlights from the Report

• Dual channel deep brain stimulation systems product segment accounted for the largest market share of around 57.8%, owing to use of advanced technology and safety features like painless management and wireless recharge to reduce tremors associated with Parkinson's disease
• Due to increase in occurrence of unconscious body movements especially in the geriatric population across the globe, Parkinson's disease application segment of the deep brain stimulation systems dominated the market with revenue share of approximately 39.7%
• Approximately, 930,000 people are expected to be suffering from the Parkinson's disease in the United States by the end of 2020. Thus, the demand for deep brain stimulation systems is set to increase significantly in the coming years with advanced features to minimise the tremors accompanying the disease
• Abbott received expanded indication from the U.S. FDA, in January 2020, for directional deep brain stimulation system to treat Parkinson's disease. With this approval the associated product will treat effectively not just Parkinson's disease but also essential tremor
• Large patient pool suffering from Parkinson's disease, epilepsy, dystonia and depression due to growing geriatric population especially in countries like India and China has stimulated the market in the Asia Pacific region. Asia Pacific registered highest CAGR of 9.0% in 2019 and is set to showcase a high rate of growth in the forecast period
• Key market players operating in the market include Abbott, Medtronic, Aleva Neurotherapeutics, NeuroPace, Cyberonics, Boston Scientific Corporation and Fisher Wallace among other companies
• North America dominated the industry with a largest market share in the deep brain stimulation (DBS) systems market. The growth prospects of the market are attributed to increase in occurrence of depression disorders, product approvals from the US Food and Drug Administration (FDA) along with favorable reimbursement scenarios and potential technological advancements in systems.

To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/deep-brain-stimulation-system-market

Emergen Research have segmented Deep Brain Stimulation (DBS) Systems Market on the basis of product, application, end use and region:

Product Outlook (Revenue in Million USD; 2017–2027)

• Dual Channel
• Single Channel

Application Outlook (Revenue in Million USD; 2017–2027)

• Fluid Replacement
• Parkinson's Disease
• Pain Management
• Obsessive-Compulsive Disorder (OCD)
• Epilepsy
• Essential Tremor
• Depression
• Dystonia
• Other

End Use Outlook (Revenue in Million USD; 2017–2027)

• Hospitals
• Ambulatory Care Centre
• Neurology Centers
• Other

Regional Outlook (Revenue in Million USD; 2017–2027)

• North America

o  US.

o  Canada

• Europe

o  Germany

o  UK

o  France

o  Spain

o  Italy

o  Rest of the Europe

• Asia Pacific

o  China

o  India

o  Japan

o  South Korea

o  Rest of Asia-Pacific

• Middle East & Africa
• Latin America

o  Brazil

Find more similar research insights by Emergen Research:

Enzymes Market Size, Share, Trends, By Source (Animals, Microorganisms, Plants), By Product (Proteases, Carbohydrase, Polymerases & Nucleases, Lipases), By Application (Specialty Enzymes, Industrial Enzymes), Forecasts to 2027

In-Vitro Diagnostics Market By Product (Reagents & Kits, Instruments), By Technique (Immunoassay, Clinical Chemistry), By Devices (Reusable IVD Devices, Disposable IVD Devices), By Application (Cancer, Infectious Diseases), By End-Use, and By Region, Forecasts to 2027

Recurrent Atrial Fibrillation Market Analysis, By Product (Devices, Drugs), By Application (EP Ablation, Diagnostic, Surgical), By End-Use (Ambulatory Surgical Centers, Cardiac Centers, Hospitals), Forecasts to 2027

Active Psoriatic Arthritis Market Analysis, By Product (Prescriptions & OTC), By Drug Class (Biologics, Non-Steroidal Anti-Inflammatory Drugs, Non-Biologic Disease Modifying Anti-Rheumatic Drugs, Other), By Route of Administration (Injectable, Oral, Topical), Forecasts to 2027

Diabetic Ketoacidosis Market Analysis, By Treatment Type (Fluid Replacement, Electrolyte Replacement, Insulin Therapy, Intermediate-Acting Insulin, Long-Acting Insulin), By End Use (Hospitals, Ambulatory Care Center, Specialty Clinics) Forecasts To 2027

Stem Cell Therapy Market By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Application (Regenerative Medicine, Drug discovery & development), By End-Users (Clinics, Hospitals), and By Region, Forecasts to 2027

About Emergen Research 

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a 'Circular Economy,' fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com
E-mail: [email protected]

Read full Press Release at : https://www.emergenresearch.com/press-release/global-deep-brain-stimulation-systems-market

SOURCE Emergen Research